Healthcare consumerism is redefining how people seek and experience medical care, relate to their healthcare providers, and actively participate in their health and well-being. Patients are now demanding easier, more tailored experiences, including easy-to-find information and access to their health data. Wearables, mobile applications, and remote monitoring solutions are driving the new norms forward.
For Med Tech firms, these shifting priorities present chances to create products that integrate seamlessly into the user’s daily experience. However, even with an appealing interface or a more convenient user experience, bringing a new medical technology to market requires establishing clinical value, meeting applicable regulations, and allowing for practical adoption.
Discussions across the medical technology ecosystem, including those associated with LSI Europe, highlight the importance of balancing patient needs with the evidence required to develop and commercialize effective healthcare solutions.
Understanding What Modern Patients Expect
Patients are now comparing their experiences at the provider’s office with their experiences with digital companies. They could demand that information be accessible, time slots be flexible, and the data is made available to them.
These expectations may determine whether a patient decides to use a certain solution and persist with it.
For Med Tech companies, insights into patients’ needs and interests are a critical part of product planning. Even if a device has a high level of technical sophistication, technical difficulty, patient discomfort or inadequate feedback can become barriers to long-term adoption.
Patient-centric design is one way organizations can mitigate these barriers and design products that are usable for their end users.
Design Medical Devices Around Everyday Routines
Technologies that are more aligned with daily habits are more likely to become integrated into everyday living.
Sensors worn on the body, smartphone apps, and passive monitoring devices can gather data as patients go about their daily lives. These tools might enable patients and their doctors to track health changes between office visits.
It is exemplified by remote patient monitoring. As it involves gathering health data away from the patient’s typical visit venues, monitoring systems offer care teams a more ongoing picture of the patient’s state, which could lead to less frequent in person visit requirements.
But ease of use alone does not necessarily lead to uptake or clinical efficacy. Enterprises need to factor in issues of reliability, access, patient training, data privacy and how this information fits into clinical workflows.
Great product strategies centre on usability and quantitative clinical benefits achieved as early in the process as possible.
Artificial Intelligence Is Expanding Patient Engagement
Artificial intelligence is opening up new methods for deriving insights from health data, recognizing patterns and enhancing the understanding of clinical information.
For patients, AI enabled tools can help simplify information and facilitate patient engagement between visits. For clinicians, relevant apps may aid in analysis and decision support.
An example of AI in diagnostics is the diagnostic app Senseye. This demonstrates the possibility of technology that can help people to access information about healthcare and diagnostics.
However, Med Tech firms should judge AI-based products based on their indicated use and their evidence of benefit. Key factors will be performance, reliability, clinical validation, quality of the data, and relevant regulatory considerations.
The question we should be asking ourselves is not: whether a device employs artificial intelligence. But rather: whether the technology targets a real clinical or patient need, and whether it offers measurable value.
Patient Engagement Must Be Supported by Clinical Evidence
While consumer-centric design may help to develop technologies that are more accessible and easier to understand, such metrics on engagement alone are not sufficient to establish clinical efficacy.
A wellness app might focus on retaining users or user satisfaction as a measure of success. For a medical device to be used for diagnosis, treatment, or monitoring, it must also show that it is functioning properly.
This disparity is crucial as digital health tools continue to expand in prevalence.
Founders should create clear evidence strategies that tie product features to important outcomes. They should describe how their product might become integrated into healthcare delivery, identify who will be its users, and define what evidence clinicians, buyers, and others will require prior to adoption.
Through integrating inclusive design and proven clinical validation, organisations can develop solutions that meet patient needs without sacrificing clinical effectiveness.
Opportunities for Medtech Founders and Investors
Healthcare consumerism is creating opportunities across several areas of medical technology.
Wearables and Connected Devices
Wearables and connected medical devices present an opportunity to ensure ongoing monitoring and gather data beyond the confines of the healthcare setting. The commercial prospects of these devices hinge on the quality of data they generate and how it leads to improved clinical outcomes or clinical decision making.
Remote Patient Monitoring
Remote monitoring enables care teams to see the patient in between office visits. For remote monitoring to be successful, your staff will need workflows, accountability for reviewing information, and a realistic method for managing alerts and patient communication.
AI Enabled Diagnostics
The AI driven diagnostic tools could aid in analyzing medical data and assist doctors in interpreting complicated information. Organizations need to build valid performance evidence and ensure regulatory compliance to their considered use cases.
Patient Friendly Digital Experiences
Mobile apps providing simple, concise, up-to-date and easily accessible medical information may help facilitate better communication between patients and clinicians. Their value over time will depend on their ease of use, accuracy, confidentiality and how well they meet the needs of healthcare.
Within each of these categories companies must link patient centered design to a viable commercialization pathway along with a well-defined clinical indication.
Balance Consumer Expectations With Healthcare Requirements
In the right conditions, a consumer Med Tech product can be a resounding success. But it must be a success for..
Patients want a technology that is intuitive, convenient, and suitable to their situation. Providers want validated data and assurance of the technology’s clinical applicability. Healthcare systems are concerned about fitting the technology into current workflows, its cost, and resource requirements. Investors want an accurate portrayal of the opportunity and how the company can deliver sustainable growth.
This can result in conflict between these needs which is why product development is optimised when input from patients and clinicians, and also technology experts and commercial stakeholders, is obtained early.
Founders must test assumptions before any substantial scale up. User research can identify problems with usability; clinical research and market research can demonstrate whether a product actually delivers real benefits and is viable to implement.
Connect With the Medtech Innovation Community
As patient centered innovation grows, it can be a key consideration for organizations, developing medical devices, digital health solutions, connected health technologies and AI enabled applications.
LSI Europe offers up-and-coming Med Tech companies opportunities to engage with investors, strategic organizations, and other stakeholders in the industry. These discussions can introduce founders to new investment interests, market barriers, and collaborators who recognize the evolution of healthcare.
Sharing with the wider Med Tech ecosystem is another useful method for companies to gain insights on what patient needs require from a commercial and clinical perspective.
What Comes Next for Consumer Centered Medtech
“The future of health-consumerism will depend on technologies that merge convenience with clinical credibility,” the paper states. “Wearables, remote monitoring solutions, connected devices and AI enabled diagnostics could unlock new avenues for how patients engage in their care.”
But sustainable uptake can only happen when products are simple to use, have convincing evidence, and they are based on real healthcare need.
With founders, designing, validating, and bringing products to market, should always be led by patient’s actions. From an investor or strategic organization’s perspective, being able to align consumer needs with proven clinical efficacy is a critical factor for assessing new technologies.
Visit LSI Europe to find the investors, innovators and strategic partners driving the development of the next generation of medical devices.
